Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
NCT05430828 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-01-22
Summary
Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.
Conditions
Interventions
- DRUG
-
Repatha (evolocumab); Praluent (alirocumab)
Dosage form: Injection
Sponsors & Collaborators
-
Federico II University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-07
- Primary Completion
- 2022-01-30
- Completion
- 2030-03-31
- FDA Drug
- Yes
Countries
- Italy
Study Locations
More Related Trials
-
MK0524B Bioequivalence Study (0524B-070)
NCT00943124 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
NCT00535405 ·Status: COMPLETED ·Phase: PHASE3
-
Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia
NCT03429998 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Alirocumab in Participants With Autosomal Dominant Hypercholesterolemia (ADH) and Gain-of-Function Mutations (GOFm) of the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Gene or Loss-of-Function Mutations (LOFm) of the Apolipoprotein (Apo) B Gene
NCT01604824 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
NCT00300482 ·Status: COMPLETED ·Phase: PHASE3
-
Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia
NCT00557778 ·Status: COMPLETED
-
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
NCT00309738 ·Status: COMPLETED ·Phase: PHASE3
-
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3
NCT01984424 ·Status: COMPLETED ·Phase: PHASE3
-
National Survey on Dyslipidemic Patients
NCT00701402 ·Status: COMPLETED
-
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
NCT03951207 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
NCT00309777 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of AD-218
NCT05400317 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
NCT01294683 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
NCT00352183 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia
NCT03811223 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
NCT01010516 ·Status: UNKNOWN ·Phase: PHASE4
-
A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia
NCT03381287 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels
NCT00749788 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
NCT00300456 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects
NCT01720537 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
NCT02100514 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
NCT00362934 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
NCT04173793 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia
NCT05255094 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
NCT07133815 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2